Continuous-flow devices and percutaneous site infections: clinical outcomes. - Wikidata - wikimedia - TriplyDB

Continuous-flow devices and percutaneous site infections: clinical outcomes.

Continuous-flow devices and percutaneous site infections: clinical outcomes.

http://www.wikidata.org/entity/Q39591032

about

Left ventricular assist device driveline infections: recent advances and future goals Technique for minimizing and treating driveline infections.Left ventricular assist devices-current state and perspectives Clinical outcomes after continuous-flow left ventricular assist device: a systematic review First series of left ventricular assist device exchanges to HeartMate 3.Pediatric ventricular assist devices: current challenges and future prospects VAD infections: the lead, the graft and the pump A review of infections in patients with left ventricular assist devices: prevention, diagnosis and management.Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices.New Treatment for Percutaneous Sites in Patients with a Ventricular Assist Device: Nihon University Crystal Violet Method.Impact of adverse events on ventricular assist device outcomes.Hospital to Home with Mechanical Circulatory Support.INTERMACS and MedaMACS: how will they guide future therapy?State of the art of mechanical circulatory support.A simple device to secure ventricular assist device driveline and prevent exit-site infection.Minimally-invasive LVAD Implantation: State of the Art.HeartWare left ventricular assist device for the treatment of advanced heart failure.Challenges faced in long term ventricular assist device support.Complications, Risk Factors, and Staffing Patterns for Noncardiac Surgery in Patients with Left Ventricular Assist Devices.Surgical management of driveline infections in patients with left ventricular assist devices.Prototype Development of an Implantable Compliance Chamber for a Total Artificial Heart.Metabolic volume performs better than SUVmax in the detection of left ventricular assist device driveline infection.The value of fluorine-18 deoxyglucose positron emission tomography scans in patients with ventricular assist device specific infections†.Reduction of INCOR® driveline infection rate with silicone at the driveline exit site.Correlation between driveline features and driveline infection in left ventricular assist device selection.Topical Polymyxin-Trimethoprim Prophylaxis May Decrease the Incidence of Driveline Infections in Patients With Continuous-Flow Left Ventricular Assist Devices.Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support.Infectious Complications of Mechanical Circulatory Support (MCS) Devices.Clinical outcomes associated with chronic antimicrobial suppression therapy in patients with continuous-flow left ventricular assist devices.Infectious complications of ventricular assist device use in children in the United States: Data from the Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs).Left Ventricular Assist Device Infections: A Systematic Review.Left ventricle assist devices and driveline's infection incidence: a single-centre experience.Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography for improving diagnosis of infection in patients on CF-LVAD: longing for more 'insights'.Five-year results of patients supported by HeartMate II: outcomes and adverse events.The current state of left ventricular assist devices: challenges facing further development.Effect of far ultraviolet light emitted from an optical diffuser on methicillin-resistant Staphylococcus aureus in vitro

P2860

Q26770293-902B9B68-8B39-4C42-8C46-2CBD15BBE4C4 Q26865692-37FEE877-18F2-4F9A-80DD-335D227605D8 Q28074655-0AEAC8A2-C23A-4E48-931F-BBBFF5F16EF3 Q30601099-9ECC74F7-24AB-469C-80B6-9B16AE4CE111 Q33168444-5C73FA1E-9F42-45C1-B8E9-56E387B12488 Q33707634-1BD685D6-FB80-4E53-A42B-CA40FE2E2E4E Q34498798-4330A80F-6831-4F5A-B02C-582845DCBAB5 Q35183405-8AA9A10D-E61E-4C39-ADB7-A7A13D06B136 Q36334445-B9F27D10-026C-4A59-94AD-24A3DDEEDF39 Q37302779-153E5A64-FE05-42C8-89B3-255CE7701D66 Q38073665-C77ED23C-1C31-4684-ACE0-3B4BB667DD3E Q38116755-18E64390-777C-4294-9B52-EE3A58EAF80A Q38123741-045F6F62-A081-4C84-8CB5-723971C39A88 Q38210201-BF9D8B67-EF43-487A-98CA-064AAFF4F4BF Q38313206-8E2114AF-BA6E-467D-8896-8DE2B238A544 Q38485093-C0B90501-5028-4465-8E87-AF4E7A6BFAD7 Q38644478-B6199220-E847-4271-B11D-327D4CC492B8 Q38845511-278941EB-4475-4AE9-89AF-5FDCCA4AFE4A Q39036332-D383A297-ED6A-478F-9136-CFFEF717A0C8 Q39263857-B1C8BB62-07EB-491F-B080-F31A699E3B89 Q39433926-00930B7E-C299-49C9-BA28-4AD556A51690 Q40197711-7F1346DC-4E4D-42CC-81A6-98FA7CAAE1C6 Q40283817-2A4F08D4-287D-415D-8ECE-C05C41E75FD7 Q40517323-5CBE618E-CECC-4098-82BD-6AB97FCFE9EE Q40603345-20B52F15-7E59-4D9B-BE7E-56EFA4BE0FE6 Q40706120-9B508031-FB61-438A-9E19-855B5BCADD9D Q41532622-F5FCA118-42FC-4D91-BF08-FB07B0B5D96B Q42246076-9E9475D0-098B-42FC-8601-B64FC014A3C0 Q43611399-1850CF97-6D77-4FA2-98CB-5B3A73C3808D Q47377102-8EFB6B5D-2251-4150-8F75-250E215ADF79 Q47388178-A5CADCEB-F29C-4746-B020-7A12F93EC62E Q47591294-7A81B6A7-6F59-4B44-A985-981A367FB9CC Q47602035-C733D337-8897-44A7-9F86-D4ABC9719857 Q47622185-B750BC64-9CA5-4FAC-AE55-A43AC0962E08 Q51662670-B5726A88-2AFA-4670-B04A-A5F4954F193F Q58791187-6C86F647-BA91-4041-BDC2-19D9E0482B30

P2860

Continuous-flow devices and percutaneous site infections: clinical outcomes.

http://www.wikidata.org/entity/Q39591032

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Continuous-flow devices and percutaneous site infections: clinical outcomes.

@en

Continuous-flow devices and percutaneous site infections: clinical outcomes.

@nl

type

label

Continuous-flow devices and percutaneous site infections: clinical outcomes.

@en

Continuous-flow devices and percutaneous site infections: clinical outcomes.

@nl

prefLabel

Continuous-flow devices and percutaneous site infections: clinical outcomes.

@en

Continuous-flow devices and percutaneous site infections: clinical outcomes.

@nl

P1433

Q39591032-666FC0AA-D1D0-480C-B995-260E539DEFC7

P1476

Q39591032-D2466774-4885-486B-B7FD-5284D0011F4A

P2093

Q39591032-1FF77EAB-4483-423C-AF00-7FFD2EF7E58D

Q39591032-4E7BA596-2ABA-430E-9024-778EECAAB28B

Q39591032-5870CC90-0618-484A-8C8C-3388C84D3C7C

Q39591032-B8FEA4BD-0E51-4198-8079-AD22166FA2CC

Q39591032-DC75DF42-61D8-40E1-AD45-158750BF2179

Q39591032-EFFE6A37-0B4A-483C-AE7F-64D4346B5525

P304

Q39591032-08833237-8F97-4594-B9F3-B20D55EC351C

P31

Q39591032-DC84F64F-F8E5-4918-B4E8-FA2C9D557EED

P356

Q39591032-9206E00B-DC1D-4D95-8DD7-C9340702E2E8

P433

Q39591032-3A708EBB-C71D-4EB5-817D-75310C8C7939

P478

Q39591032-B948220B-9010-4314-9B19-A8684ECF0A9E

P50

Q39591032-44C74542-D130-499C-8A56-B5F530742B95

P577

Q39591032-56B00545-3694-48C8-8646-FF0A794B7797

P698

Q39591032-46ACDC77-A53D-4EC2-BDCE-BB87DA3CCC61

P356

J.HEALUN.2012.05.004

P1433

The Journal of Heart and Lung Transplantation

P1476

Continuous-flow devices and percutaneous site infections: clinical outcomes

@en

P2093

Daniel J Goldstein

http://www.w3.org/2001/XMLSchema#string

David Naftel

http://www.w3.org/2001/XMLSchema#string

James Kirklin

http://www.w3.org/2001/XMLSchema#string

Lavanya Bellumkonda

http://www.w3.org/2001/XMLSchema#string

Salpy V Pamboukian

http://www.w3.org/2001/XMLSchema#string

William Holman

http://www.w3.org/2001/XMLSchema#string

P304

1151-1157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HEALUN.2012.05.004

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Francis D. Pagani

P577

2012-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22766022

http://www.w3.org/2001/XMLSchema#string